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Cellular/Molecular
Chimeric Glutamate Receptor Subunits Reveal the
Transmembrane Domain Is Sufficient for NMDA Receptor
Pore Properties but Some Positive Allosteric Modulators
Require Additional Domains
Timothy J. Wilding, Melany N. Lopez, and XJames E. Huettner
Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110
NMDAreceptors are ligand-gated ion channels that underlie transmission at excitatory synapses andplay an important role in regulating
synaptic strength and stability. Functional NMDA receptors require two copies of the GluN1 subunit coassembled with GluN2 (and/or
GluN3) subunits into a heteromeric tetramer. A diverse array of allosteric modulators can upregulate or downregulate NMDA receptor
activity. These modulators include both synthetic compounds and endogenous modulators, such as cis-unsaturated fatty acids, 24(S)-
hydroxycholesterol, and various neurosteroids. To evaluate the structural requirements for the formation and allosteric modulation of
NMDAreceptorpores,wehave replacedportions of the ratGluN1,GluN2A, andGluN2Bsubunitswithhomologous segments from the rat
GluK2 kainate receptor subunit. Our results with these chimeric constructs show that the NMDA receptor transmembrane domain is
sufficient to account for most pore properties, but that regulation by some allosteric modulators requires additional cytoplasmic or
extracellular domains.
Key words: carboxy terminal domain; docosahexaenoic acid; palmitoylation
Introduction
Vertebrate central neurons express multiple receptors for the ex-
citatory neurotransmitter L-glutamate, including three different
families of ionotropic receptors (iGluRs) named for the agonists
NMDA, AMPA, and kainate (Traynelis et al., 2010). Distinct sets
of subunits, with limited primary sequence identity, contribute to
these three iGluR families (Traynelis et al., 2010), but they all
share a similarmodular organization that includes large extracel-
lular amino-terminal and ligand-binding domains (ATDs and
LBDs), a transmembrane domain (TMD) that forms the channel
pore (Huettner, 2015), and a cytoplasmic carboxy terminal do-
main (CTD; Sobolevsky et al., 2009; Karakas and Furukawa,
2014; Lee et al., 2014). Functional iGluRs are tetramers that, in
the case of NMDA receptors, require two GluN1 subunits com-
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Significance Statement
Glutamate receptorsmediate excitatory synaptic transmissionby forming cation channels through themembrane that openupon
glutamate binding. Although many compounds have been identified that regulate glutamate receptor activity, in most cases the
detailedmechanisms that underliemodulation are poorly understood. To identifywhat parts of the receptor are essential for pore
formation and sensitivity to allosteric modulators, we generated chimeric subunits that combined segments from NMDA and
kainate receptors, subtypes with distinct pharmacological profiles. Surprisingly, our results identify separate domain require-
ments for allosteric potentiation of NMDA receptor pores by pregnenolone sulfate, 24(S)-hydroxycholesterol, and docosa-
hexaenoic acid, three endogenous modulators derived from membrane constituents. Understanding where and how these
compounds act on NMDA receptors should aid in designing better therapeutic agents.
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bined in a heterotetramer with GluN2
and/or GluN3 subunits, of which there
are four (GluN2A–GluN2D) and two
(GluN3A and GluN3B) subtypes, respec-
tively (Paoletti et al., 2013). Additional di-
versity arises from alternate splicing of
GluN1 and post-translational modifica-
tions, including phosphorylation and pal-
mitoylation of specific residues in the
subunit CTDs (Collingridge et al., 2013).
Conventional NMDA receptors, made
up of GluN1 and GluN2 subunits, require
coactivation by glutamate, which binds to
the GluN2 subunit, and glycine or
D-serine, which bind to GluN1 (Traynelis
et al., 2010). This subunit combination
forms channels that exhibit voltage-
dependent block by magnesium but high
permeability to monovalent cations and
calcium. Because calcium entry through
the channels requires both presynaptic
transmitter release and postsynaptic de-
polarization to removemagnesium block,
this unique permeation profile underlies
the ability of NMDA receptors to regulate
plasticity at excitatory synapses by detect-
ing coincidence of presynaptic and post-
synaptic activity (Paoletti et al., 2013).
NMDA receptors are subject to regu-
lation by a wide variety of different
compounds (Traynelis et al., 2010; Col-
lingridge et al., 2013; Zhu and Paoletti,
2015), including several endogenous
modulators derived from constituents of
the plasmamembrane. Both-6 and-3
cis-unsaturated fatty acids, such as arachi-
donic acid (AA) and docosahexaenoic
acid (DHA), potentiate neuronal and re-
combinant NMDA receptors (Miller et
al., 1992; Nishikawa et al., 1994), whereas
lysophospholipids are inhibitory (Casado
and Ascher, 1998). In addition, a number
of endogenous steroid compounds, in-
cluding neurosteroids (Gibbs et al., 2006;
Korinek et al., 2011) and cholesterol me-
tabolites (Paul et al., 2013; Linsenbardt et
al., 2014; Korinek et al., 2015), have been
shown to exhibit selective potentiation or
inhibition of NMDA receptor-mediated
currents. Most of these compounds
appear to upregulate or downregulate
channel open probability; however, the
molecular interactions that underlie
modulation remain largely unknown. In-
deed, for some of the compounds, it is not
Figure 1. Heteromeric subunit chimeras form functional NMDA receptor pores. A, Protein sequence at the five joints used to
construct the chimeric subunits inB.B, Simplified diagram of the four domains in two chimeric subunits of a heteromeric receptor
highlighting the pore loop and  helical segments in the TMD derived from the GluN1 (blue) or GluN2 (red) subunit. Non-TMD
portionsof each chimeraderived fromtheGluK2kainate receptor subunit are shown inblack. SubunitswithN1andN2extracellular
domains are presumed to be adjacent in functional tetramers. For clarity, the subunits are positioned opposite each other in the
diagram. C, Mean peak whole-cell agonist-evoked current ( SEM) recorded at80mV in HEK 293 cells transiently transfected
with chimeric subunit cDNAs and activated with either 10M kainate (LBD from GluK2) or 10M NMDA and 10M glycine (LBDs
from NMDA receptor subunits). Agonist-evoked inward currents were significant (i.e., different from zero, t-statistic) for all of the
coexpressed construct combinations, but not for any of the chimeric constructs expressed alone.D, I–V for agonist-evoked current
4
recorded as themembrane potential was ramped from110
to60mVat 0.75mVms 1 in the presence (red) or absence
(black) of 1 mM external magnesium. All recordings from
GluN1/2B chimeras. Voltage axis ticks, 50 mV; current axis
ticks, 200 pA; except TMD, 500 pA.
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clear whether they bind to specific locations on the receptor or
exert an indirect influence on channel gating via changes in bulk
membrane properties (Casado and Ascher, 1998). Neurosteroids
have recently become a focus of drug development and together
with oxysterols and cis-unsaturated fatty acids may offer novel
targets for therapeutic intervention to reduce excessive NMDA
receptor activation.
In the present study we sought to determine which glutamate
receptor domains are required forNMDA receptor channel func-
tion and allosteric modulation.We generated a series of chimeric
subunits that swap domains between kainate receptor subunit
GluK2 and NMDA receptor subunits GluN1 and GluN2A or
GluN2B (Wilding et al., 2014). Our results show that the TMDs
fromGluN1 andGluN2, together with the short linkers that con-
nect to their respective LBDs, are sufficient to form functional
channels with characteristic features ofNMDA receptors, includ-
ing voltage-dependent block by magnesium and organic pore
blockers, permeability to calcium, and positive allosteric modu-
lation by 24(S)-hydroxycholesterol [24(S)-HC; Paul et al., 2013].
In contrast, current potentiation by cis-unsaturated fatty acids
required additional membrane proximal portions of the cyto-
plasmic CTD, whereas potentiation by the neurosteroid preg-
nenolone sulfate (PS; Wu et al., 1991) was only observed in
chimeric receptors that included the LBDandTMD fromNMDA
receptor subunits.
Materials andMethods
cDNA constructs, cell culture, and transfection. Rat subunit cDNAs were
generously provided by Steve Heinemann, Peter Seeburg, Mark Mayer,
StefanoVicini, and LindaNowak. Chimeric subunits were produced by a
restriction enzyme-free PCR cloning method (Tillett and Neilan, 1999)
or by ligation of PCR products with novel restriction sites inserted by
silent mutations. All constructs were sequenced by the Washington
University Protein Nucleic Acid Chemistry Laboratory. cDNAs were
expressed by transient transfection in HEK 293 cells using lipo-
fectamine 2000 (Invitrogen). The cells were propagated in 25 cm2
flasks with MEM plus 10% fetal bovine serum and passaged once each
week with protease XXIII (Sigma-Aldrich). Cells used for transfection
were seeded onto 12-well plates and transfected the following day.
Coexpression of GFP from a second vector was used to identify trans-
fected cells. The day after transfection, cells were plated at low density
on 35 mm plates coated with nitrocellulose; recordings were obtained
on the following 2 d.
Electrophysiology. Cultures were bath perfused with Tyrode’s solution
containing the following (in mM): 150 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10
glucose, 10 HEPES, pH 7.4 with NaOH. Whole-cell electrodes were
pulled from borosilicate tubing (WPI) and filled with an internal solu-
tion that contained the following (inmM): 140Cs-glucuronate, 10 EGTA,
5 CsCl, 5 MgCl2, 5 ATP, 1 GTP, and 10 HEPES, pH adjusted to 7.4 with
CsOH. Agonists and antagonists were delivered in control extracellular
solution (160 mMNaCl, 2 mM CaCl2, and 10 mMHEPES, pH adjusted to
7.4 with NaOH) by local perfusion from a multibarreled pipette posi-
tioned near the recorded cell. Currents were recorded with an Axopatch
200A amplifier controlled by p-Clamp software (Molecular Devices) and
are presented as mean  SEM agonist-evoked current (current during
agonist exposure minus holding current recorded in control solution
before and/or after agonist superfusion). Chimeras with LBDs from
GluK2 were treated with concanavalin A to increase steady-state agonist
responses for most experiments (Wilding et al., 2005).
Current–voltage relations (I–Vs) were generated by averaging the cur-
rents recorded during a series of five ascending and descending mem-
brane potential ramps (0.75mVms1). I–Vs recorded in the presence of
magnesium were fit with a Boltzmann function: I (a Vm)  [b c/
(1 exp[(VmV1/2)/k])] to compare the half-maximal voltage (V1/2)
and slope factor (k) for magnesium block. Statistical significance was
assigned for p 0.05.
Molecular modeling. Homology modeling was performed in Modeler
(release 9.7; Eswar et al., 2008) using multiple templates (4PE5: Karakas
and Furukawa, 2014; 4TLM: Lee et al., 2014) and twofold symmetry
constraint for the A/C and B/D subunit pairs. Predictions for CTD sec-
ondary structure were made with JPred3 (Cole et al., 2008) and PEP-
FOLD (The´venet et al., 2012), with subsequent loop-refinement in
Modeler.
Results
Chimeric channels with heteromeric NMDA receptor pores
To determine the structural requirements for allosteric modula-
tion of receptors withNMDA receptor pore properties (Traynelis
et al., 2010; Huettner, 2015), we generated a number of chimeric
subunit constructs that replaced domains of GluN1, GluN2A,
and/or GluN2B with the homologous domain from the GluK2
kainate receptor subunit (Fig. 1A,B). All of our initial chimeric
constructs contained the full NMDA receptor TMD, including
the transmembrane M4 helix and the linkers that connect the
TMD and LBD (Fig. 1A,B). Agonist applications failed to evoke
significant current in HEK cells transfected with any of the chi-
meric subunits alone (Fig. 1C), indicating that they were unable
to form functional homomeric channels. However, cotransfec-
tion of GluN1 and GluN2 TMD-containing subunits together
resulted in substantial currents activated by the agonist(s) appro-
priate for the LBD: kainate for chimeric subunits that included
the LBD from GluK2 or NMDA and glycine for subunit combi-
nations that contained the LBDs from GluN1 and GluN2 (Fig.
1C). Each functional combination of homologous constructs dis-
played voltage-dependent block by magnesium (Fig. 1D; Table
1), a characteristic feature of intact NMDA receptors (Mayer et
al., 1984; Nowak et al., 1984) mediated by adjacent asparagine
residues near the apex of the GluN2 subunit pore loop (Burna-
shev et al., 1992; Wollmuth et al., 1998). In addition, I–Vs re-
corded in normal and elevated calcium (2 and 10 mM) indicated
substantial calcium permeability for the chimeric receptors with
NMDA receptor pores (Fig. 2A). Based on the change in reversal
potential between the two external solutions of 7.5  0.5 mV
(n 72), the permeability ratio for calcium to sodium (PCa/PNa)
was estimated at 4.4  0.4, which is consistent with previous
work on recombinant wild-type receptors (Jatzke et al., 2002).
Finally, chimeric receptors displayed voltage-dependent inhibi-
tion by ketamine (Fig. 2B), one of several organic blockers that
can be trapped within the closed NMDA receptor channel
Table 1. Boltzmann parameters for voltage-dependentmagnesium block
Construct Slope V1/2 #
GluN2A
Wild type 14.7 1.2 31.3 4.3 8
TMD 16.7 1.3 20.2 2.6 4
LBD TMD 15.3 0.4 25.9 3.0 7
ATD LBD TMD 14.6 0.3 25.9 6.8 7
TMD CTD 17.1 1.2 18.5 4.9 6
LBD TMD CTD 13.7 0.3 6.7 1.6* 14
GluN2B
Wild type 12.1 0.5 16.8 1.5 16
TMD 13.7 0.5 32.1 4.9 14
ATD TMD 15.0 1.0 18.1 5.2 6
LBD TMD 15.0 0.4 15.8 3.9 15
ATD LBD TMD 14.9 0.6 18.5 1.9 3
TMD CTD 14.4 0.9 12.1 3.0 3
ATD TMD CTD 12.8 1.2 21.6 4.0 3
LBD TMD CTD 13.8 0.2 6.8 1.8* 14
Slope factors (k) andV1/2 valueswereobtained frombest fits of aBoltzmann function: I (aVm ) b c / (1
exp(VmV1/2 )/k	)	 to I–V in thepresenceof 1mMmagnesium.EachGluN2constructwas coexpressedwith the
homologous GluN1.1 construct. * denotes significant difference from wild type (ANOVA on ranks with post-hoc
Dunn’s test).
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(Traynelis et al., 2010). Block by 30 M
ketamine was essentially complete at80
mV (99.8  2.3%, n  90) but substan-
tially weaker at 40 mV (65.5  4.9%,
n  11). In addition, the potency of ket-
amine block was similar for wild-type
NMDA receptors and constructs in which
only the TMD and linkers came from
NMDA receptors (Fig. 2C,D). Thus, the
results in Figures 1 and 2 indicate that the
TMD and linker regions from the GluN1
and GluN2 subunits are together suffi-
cient to specify formation of a functional
NMDA receptor pore. These results com-
plement our earlier work (Wilding et al.,
2014), which showed that chimeric sub-
units with the TMD and linkers from
GluK2 transplanted into either GluN1 or
GluN2B fail to function as homote-
tramers but form functional heteromeric
channels with kainate receptor pore prop-
erties upon coexpression. Together, these
experiments support the idea that deter-
minants for NMDA receptor subunit
heteromerization are distributed across
multiple iGluR domains (Ayalon and
Stern-Bach, 2001).
Domain requirements for positive
allosteric modulation
NMDA receptor activity can be potentiated
by exposure to a number of different mem-
brane-derived modulatory compounds in-
cluding AA and DHA (Miller et al., 1992;
Nishikawa et al., 1994), 24(S)-HC (Paul et
al., 2013), and PS (Wu et al., 1991). To eval-
uate the structural basis for thismodulation,
we recorded from HEK cells transfected
with chimeric subunits and compared the
amplitude of agonist-evoked currents be-
fore and immediately after exposure to
24(S)-HC (Fig. 3), PS (Fig. 4), or DHA
(Fig. 5). As shown in Figure 3, ago-
nist-evoked whole-cell currents increased
following exposure to 24(S)-HC in hetero-
meric chimeric combinations that included the NMDA receptor
TMD, whereas treatment with 24(S)-HC had no effect on edited or
unedited homomeric wild-type GluK2 receptors or on heteromeric
chimeric receptors with the extracellular ATD and LBD from
NMDAreceptors fused to theTMDandCTDfromGluK2 (Wilding
et al., 2014). Together, these results strongly suggest that theNMDA
receptorTMDalone isnecessaryandsufficient todeterminechannel
modulation by 24(S)-HC.
In contrast to 24(S)-HC,which potentiated constructswith an
NMDA receptor TMD (Fig. 3), PS and DHA affected distinct
subsets of the chimeric receptors depending upon the presence of
additional NMDA receptor domains. Consistent with previous
evidence that potentiation by PS involves interaction with the
NMDA receptor LBD (Jang et al., 2004; Horak et al., 2006), we
observed substantial potentiation by PS of chimeric receptors
that included both the TMD and LBD from NMDA receptor
subunits (Fig. 4), but significantly less effect on chimeric con-
structs that lacked the NMDA receptor LBD. In addition, PS did
not potentiate currents mediated by edited or unedited GluK2
receptors. Importantly, exposure to PS did not cause significant
potentiation of currents mediated by the chimeric construct with
NMDA receptor ATD and LBD fused to the TMD andCTD from
GluK2. Collectively, these results confirm earlier evidence that
interaction with the LBD is required for allosteric potentiation of
NMDA receptor channels by PS. Additional portions of the link-
ers and M4 helix may also be essential (Korinek et al., 2011;
Kostakis et al., 2011) as chimeric receptors that included the kai-
nate receptor TMD and linkers were not potentiated by PS even
when activated by NMDA and glycine binding to the NMDA
receptor LBD.
Unlike PS and 24(S)-HC, exposure to AA and DHA modu-
lates activity of both NMDA and kainate receptors, potentiating
NMDA-evoked currents in neurons (Miller et al., 1992) and in-
hibiting currents mediated by neuronal kainate receptors (Wild-
ing et al., 1998). In addition, work on recombinant wild-type and
mutant or chimeric subunits indicates that the kainate receptor
Figure2. Calciumpermeability and ketamine block of chimeric channels.A,Whole-cell current evoked by 10MNMDAplus 10
Mglycine as a function of voltage asmembranepotentialwas ramped from110 to60mVat 0.75mVms 1 in 160mMNaCl,
10 mM HEPES with 2 mM CaCl2 (black), or with 10 mM CaCl2 (green), or with 2 mM CaCl2 and 1 mM MgCl2 (red). Note the rightward
shift in reversal potential in elevated calcium. GluN1/2A TMD.B, Exposure to 30Mketamine (black bars) blocks current evokedby
10M kainate (open bars) at80mV, and to a lesser extent at40mV. GluN1/2A TMD. C, Whole-cell current evoked by 10M
kainate is blocked progressively by 1, 3, 10, and 30 M katamine. GluN1/2A TMD. D, Current in the presence of ketamine as a
fraction of control (mean SEM) is plotted as a function of ketamine concentration. Smooth curves are best fits of 1/(1
[(ketamine)/IC50]
n)where IC50 is the concentration producing half-maximal inhibition andn is the slope factor. Values for chimeric
constructs (N1/2A: IC502.60.2,n1.90.3, 7 cells; N1/2B: IC501.70.1,n2.00.3, 9 cells)werenot significantly
different from those of the respective wild-type subunits (N1/2A: IC50 2.0 0.1M, n 1.4 0.2, 13 cells; N1/2B: IC50
1.6 0.2, n 1.7 0.2, 10 cells) by t test.
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TMD is sufficient to determine the effect
of DHA exposure on pore operation
(Wilding et al., 2014). Strong inhibition of
GluK2 by DHA requires the presence of
arginine at the glutamine/arginine (Q/R)
editing site of all four subunits in the te-
tramer, both for wild-type full-length ho-
momericGluK2 (Wilding et al., 2005) and
for chimeric receptors with the GluK2
TMD (Wilding et al., 2014).Moreover, an
M3 helix Leu to Ala substitution at the
level of the central cavity converts inhi-
bition of edited (R) channels to poten-
tiation, both for full-length GluK2(R)
(Lopez et al., 2013) and for chimeric chan-
nels that include the TMD and linker seg-
ments from GluK2 combined with the
ATD and LBD from NMDA receptor
subunits (Wilding et al., 2014). In sharp
contrast to the evidence that DHAmodu-
lation targets the kainate receptor TMD,
potentiation of NMDA receptor channels
by DHA was only observed for chimeric
constructs that included both the TMD
and CTD from NMDA receptors. As
shown in Figure 5, exposure to DHA had
no significant effect on constructs in
which the CTDs of both the GluN1 and
GluN2 subunits were replaced with the
GluK2 CTD but potentiated currents
mediated by constructs that included
both the TMD and CTD from NMDA re-
ceptors.
Requirement for membrane proximal
portions of the GluN2 CTD
To rule out the possibility that elements
within the GluK2 CTD might be incom-
patible with NMDA receptor channel po-
tentiation by DHA, we generated deletion
constructs with stop codons immediately
after M4 corresponding to position K841
in GluN1 and R846 or R847 in GluN2A or
GluN2B, respectively. As shown in Figure
6A,C, currents evoked by NMDA and
glycine in cells cotransfected with both
deletion constructs, or either deletion
construct together with a full-length part-
ner, were unaffected by exposure to DHA,
suggesting a requirement for bothNMDA
receptor CTDs. However, we also tested
combinations in which only the GluN1
CTDor only theGluN2CTDwas replaced
with the kainate receptor CTD from
GluK2 (Fig. 6B,C). DHA potentiated re-
ceptors that included full-length GluN2A
or GluN2B together with chimeric GluN1
bearing the CTD from GluK2, albeit to a
lesser extent than completely wild-type
receptors. In contrast, DHA had no eff-
ect on receptors comprising full-length
GluN1 paired with chimeric GluN2A or
GluN2B subunits bearing the GluK2 CTD
Figure 3. Potentiation by 24(S)-HC only requires the NMDA receptor TMD. A, Exposure to 10 M 24(S)-HC (shaded bar)
potentiated whole-cell current evoked by 10M kainate (open bars) in an HEK cell transfected with the N1/N2B TMD chimera. B,
Minimal effect of 24(S)-HC on the N1/N2B ATDLBD chimera activated by 10M NMDA plus 10M glycine. C, Plot of current
(mean  SEM) evoked after exposure to 24(S)-HC as a fraction of control current before 24(S)-HC treatment. *, Significant
difference fromwild-typeGluN1/2Bwas observed for homomeric GluK2 (Qor R) and for theN1/N2BATDLBD chimera,whichhas
an unedited (Q) kainate receptor TMD but not for chimeric constructs with the NMDA receptor LBDTMD or TMD alone ( p
0.001, ANOVA on ranks with post hoc Dunn’s test).
Figure 4. PS potentiates chimeric channels that include the NMDA receptor LBD and TMD.A,B, Exposure to 100M PS (shaded bar)
potentiateswhole-cell currentevokedby10MNMDAplus10Mglycine inanHEKcell transfectedwiththeN1/N2BLBDTMDchimeric
subunits(A),butnotinacell transfectedwiththeN1/N2BTMD-alonechimera(B).C,Plotofcurrent(meanSEM)evokedduringexposure
to PS as a fraction of control current before PS treatment. *, Significant difference fromwild-type GluN1/2Bwas observed for homomeric
GluK2 (Q or R), for heteromeric chimeraswith theN1/2B TMDand linkerswithout the LBDand for theN1/N2BATDLBD chimera,which
has an unedited (Q) kainate receptor TMD; however, potentiation for the chimeric constructwith theNMDA receptor LBDTMDwas not
significantly different fromN1/2B. (p0.001, ANOVAon rankswithpost hocDunn’s test).
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(Fig. 6B,C). Together, these results indicate that fatty-acid po-
tentiation requires the GluN2 CTD, but on the GluN1 subunit
either the native wild-type CTD or the GluK2 CTD will suffice.
Additional deletionmutants were created to determine which
portion of the GluN2 CTDwas essential. Potentiation was main-
tained with truncation after position 931 in either GluN2A or
GluN2B, resulting in deletion of the C-terminal 526 or 544 aa,
respectively (Fig. 7A–C). Weaker potentiation was also observed
formore proximal truncation after residue 877 of GluN2A or 878
of GluN2B, but not for several additional truncations closer to
M4 (Fig. 7A–C; data not shown). These results suggest that the
proximal GluN2 CTD is necessary for NMDA receptor potenti-
ation by DHA. Our previous work (Wilding et al., 2014) indi-
cated that kainate receptor modulation by DHA was similar for
wild-type GluK2 and for chimeric receptors with a TMD from
GluK2, heteromeric ATD and LBD from NMDA receptors, and
either the GluK2 CTD or heteromeric NMDA receptor CTDs. In
the present study we also tested whether the proximal GluN2
CTD alone was sufficient to modify the effect of DHA on homo-
meric edited (R) or unedited (Q) GluK2. As shown in Figure 7D,
DHA inhibition of GluK2(R) was unchanged by substitution of
the GluN2B CTD. Wild-type GluK2(Q) is unaffected by DHA,
whereas receptors substitutedwith theGluN2BCTDwereweakly
inhibited. Collectively, these results suggest that the GluN2 prox-
imal CTD renders the NMDA receptor TMD susceptible to po-
tentiation by DHA, but has minimal effect on the GluK2 TMD.
Cysteine replacement in the proximal CTD reduces
potentiation by DHA
Previous biochemical studies have identified a number of post-
translational modification sites within the minimal essential re-
gion of the GluN2 CTD identified in Figure 7, including a cluster
of cysteine residues that can undergo palmitoylation (Hayashi et
al., 2009;Mattison et al., 2012) and a conserved tyrosine thatmay
be phosphorylated by Src kinase (Vissel et al., 2001). As an initial
test for whether any of these potential modification sites are re-
quired for allosteric modulation by DHA, we generated mutant
versions of GluN2A and GluN2B with Y-to-F substitution at the
conserved tyrosine and C-to-A substitution at all three of the
proximal cysteines. An additional cysteine (C838) located near
the cytoplasmic end of M4 in GluN2B was substituted with Trp,
the residue at the homologous position in GluN2A. As shown in
Figure 8, full-length receptors bearing all of these substitutions
were unaffected by exposure to DHA. Additional mutant full-
length GluN2A constructs revealed that potentiation by DHA
was reduced relative to wild-type for all of the single, double, or
triple substitutions in the proximal cysteine cluster, but was least
affected for the Y842F substitution, which exhibited significant
increases in agonist-gated current after DHA exposure (Fig.
8A,B). Together, these results strengthen the evidence for in-
volvement of the proximal CTD in allostericmodulation byDHA
and raise the possibility that cysteine modification could be a
contributory factor.
Although there is no x-ray crystal structure available for any of
the iGluRCTDs, algorithms that predict secondary structure sug-
gest that there may be several  helical segments within the prox-
imal CTD of each iGluR subunit (Ryan et al., 2008). Theminimal
GluN2 cytoplasmic domain essential for DHA potentiation in-
cludes a predicted helical region between C2 and C3 that encom-
passes a conserved SRGIYSC sequence (Fig. 7A) that is present in
all four GluN2 subunits. Although the helical properties of this
proximal CTD segment require structural confirmation, together
our results suggest a hypothetical model for the GluN2 proximal
CTD shown in Figure 9.
Discussion
Our results support several conclusions about iGluR structure,
operation, and regulation by positive allostericmodulators. First,
we show that GluN1 and GluN2 subunit TMDs and linkers in-
clude sufficient constraints for the assembly of functional hetero-
Figure 5. DHA potentiates chimeric channels that include the NMDA receptor TMD and CTD.
A, Exposure to 15 M DHA (shaded bar) potentiated whole-cell current evoked by 10 M
kainate (open bars) in an HEK cell transfected with the N1/N2B TMDCTD chimera. B, Lack of
effect of DHA on the N1/N2B TMD chimera. C, Plot of current (mean SEM) evoked immedi-
ately after exposure to DHA as a fraction of control current before DHA treatment. *, Significant
potentiation for chimeric constructs with the NMDA receptor TMDCTD, but not for chimeras
that included the NMDA receptor TMD and linkers without the CTD ( p 0.05, Mann–Whitney
rank-sum tests).
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meric tetramers. Chimeric subunits that included GluN1 or
GluN2 TMDs and linkers failed to generate functional channels
when expressed alone, but heteromeric coexpression gave rise to
robust agonist-gated currents that displayed signature features of
NMDA receptor pores, including permeability to calcium and
voltage-dependent block bymagnesium and ketamine (Traynelis
et al., 2010). Second, we demonstrate distinct domain require-
ments for positive allosteric modulation by three membrane-
derived regulators. The cholesterol metabolite 24(S)-HC had no
effect on homomeric GluK2 but strongly potentiated chimeric
channels that included the TMD and linkers fromNMDA recep-
tor subunits. Potentiation by the neurosteroid PS required both
the LBD and TMD from NMDA receptors, confirming earlier
mutation studies (Jang et al., 2004; Horak et al., 2006). In con-
trast, potentiation by DHA did not require the NMDA receptor
LBD but was only observed for chimeric channels that included a
proximal portion of the GluN2 subunit CTD.
Functional NMDA/kainate receptor
subunit chimeras
Although much remains to be learned
about specification of specific subunit
combinations, there is growing evidence
that several distinct domain interac-
tions contribute to production of het-
eromeric iGluRs (Traynelis et al., 2010;
Herguedas et al., 2013). For NMDA re-
ceptors, assembly as obligate heterote-
tramers is thought to involve initial
association controlled by the extracellu-
lar ATDs (Hansen et al., 2010). Indeed,
our earlier work showed that chimeric
subunits with the extracellular domains
fromNMDA receptors and a transmem-
brane and cytoplasmic portion from
GluK2 kainate receptors fail to function
as homotetramers but only form func-
tional channels when coexpressed as
N1/K2N2B/K2 heteromers (Wilding
et al., 2014). Thus, NMDA receptor ex-
tracellular domains are sufficient to
impose a requirement for heterome-
rization onto the kainate receptor pore
(Wilding et al., 2014), despite the fact
that native full-length GluK2 forms
functional homotetramers (Egebjerg et
al., 1991).
In this study we found that interac-
tions promoting heteromerization are
also present within the NMDA receptor
TMD and linkers (Ayalon and Stern-
Bach, 2001). Previous work (Villmann et
al., 1999; Liu and Nowak, 2000) showed
that chimeric subunits in which only the
M1–M3 pore domain from GluN1 was
transplanted into GluK2 formed func-
tional homomeric channels that were
activated by kainate, suggesting the ho-
momeric extracellular domains from
GluK2 enabled assembly of a chimeric
pore. However, similar constructs using
M1–M3 from GluN2B failed to function
as homomeric channels or when coex-
pressed with GluN1 pore-domain chime-
ras (Villmann et al., 2008). Moreover, chimeric GluN1 M1–M3
homomers lacked characteristic NMDA receptor features
(Villmann et al., 1999), including voltage-dependentmagnesium
and MK-801 block, properties preserved in our constructs that
swap the entire TMD including linkers to the LBD and the M4
helix. Previous studies have highlighted the importance of theM4
helix for iGluR assembly and function (Schorge and Colquhoun,
2003; Terhag et al., 2010; Salussolia et al., 2013). In addition,
recent NMDA receptor crystal structures (Karakas and Furu-
kawa, 2014; Lee et al., 2014) confirm extensive contact between
GluN1 and GluN2 involving the M4 helix of each subunit with
M1 and M3 helices of the adjacent heteromeric subunit. Our
results suggest that this M4-mediated contact is sufficient to al-
low for heteromeric association of theM1–M3 pore domain into
functional channels sensitive to magnesium and ketamine as ex-
pected for native NMDA receptors.
Figure 6. DHA potentiation requires the GluN2 CTD. A, Exposure to 15M DHA (shaded bars) did not potentiate whole-cell
currents evoked by 10MNMDAplus 10Mglycine (open bars) in HEK cells cotransfectedwith truncated GluN1840 andGluN2B846
(top trace), or for cotransfection of a wild-type and a truncated subunit: GluN1840/GluN2Bwt (middle trace), GluN1wt/GluN2B846
(bottom trace).B, Exposure to 15MDHA (shadedbar) potentiatedwhole-cell current evoked by 10MNMDAplus 10Mglycine
(open bars) in an HEK cell transfectedwith a GluN1 chimera bearing a GluK2 CTD andwild-type GluN2B (top); lack of effect of DHA
onwild-type GluN1with the GluN2B chimera bearing a GluK2 CTD (bottom). C, Plot of current (mean SEM) evoked immediately
after exposure to DHAas a fraction of control current before DHA treatment forwild-type and truncated or chimeric NMDA receptor
subunits. *, Significant difference from wild-type ( p 0.0001, ANOVA on ranks with post hoc Dunn’s test) and not significantly
different fromnoeffect (i.e., IDHA/Icontrol1, t-statistic). # denotes that for theN1 (K2CTD)/N2wild-type combinations IDHA/Icontrol
was significantly
1 but also significantly less than that for wild-type receptors. Inset, Proximal CTD sequences of GluN1, GluN2A,
and GluN2B. Shading denotes truncation after N1 H840, 2A L845, and 2B F846.
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Domain requirements for positive
allosteric modulation
In addition to competitive antagonists and
channel blockers, a diverse assortment of al-
losteric regulatorshavebeen showntomod-
ify the operation of NMDA receptors,
including endogenous molecules, such as
polyamines, zinc, fatty acids, lysophospho-
lipids, and cholesterolmetabolites, aswell as
a growing repertoire of synthetic com-
pounds (Collingridge et al., 2013; Zhu and
Paoletti, 2015). Binding sites and mecha-
nisms of modulation have been proposed
for a number of these allosteric modulators
(Zhu and Paoletti, 2015), but inmany cases
the basis for regulation remains incom-
pletely understood. Our results using chi-
meric subunits to evaluate three positive
allosteric modulators derived from compo-
nents of the lipid bilayer revealed three dis-
tinct domain requirements: PS (Jang et al.,
2004; Horak et al., 2006) required the
NMDA receptor LBD and TMD, whereas
24(S)-HC potentiated chimeras that only
included theTMDand linkers fromNMDA
receptors combined with the ATD, LBD,
and CTD from GluK2. Recent work sug-
gests that 24(S)-HC (Paul et al., 2013) acts
by a different mechanism than either PS or
cis-unsaturated fattyacidsaspotentiationby
24(S)-HC does not occlude modulation by
PSorAA. Inaddition, the25-hydroxyderiv-
ative of cholesterol noncompetitively re-
duces potentiation by 24(S)-HC but does
not prevent potentiation by PS or AA (Lin-
senbardt et al., 2014). Thus, our results sug-
gesting distinct structural requirements for
allosteric modulation are broadly consis-
tent with recent analysis of oxysterol
pharmacology.
The finding that potentiation by fatty
acid exposure requires a proximal seg-
ment of the GluN2 CTD was not ex-
pected. Our recent work on chimeric
receptors with kainate receptor pores re-
vealed that DHA produced similar modu-
lation of the GluK2 TMD and linkers
regardless whether the CTD came from
GluK2 or from GluN1/2B (Wilding et al.,
2014). In addition, earlier work byCasado
and Ascher (1998) had suggested that
NMDA receptor modulation by AA and
lysophospholipids, as well as mechano-
sensitivity (Paoletti andAscher, 1994), did
not involve the CTD. They showed that
channelmodulation bymechanical defor-
mation of themembrane was preserved in
truncated mutants lacking either the
GluN1 CTD or the distal CTD of GluN2A
(terminated at residue 1082 or 1438). Channel inhibition by ly-
sophosphatidyl inositol persisted in receptors with proximal
GluN2A CTD truncation at position 844; however, the effect on
mechanosensitivity or potentiation by AA was not reported
(Casado and Ascher, 1998). In addition, modulation by lyso-
phospholipids was only observed with extracellular application.
Several groups have reported consistent potentiation of NMDA
receptors byAAorDHAapplied to outside-out patches (Miller et
Figure 7. The GluN2 proximal CTD supports NMDA receptor TMD potentiation. A, Sequence of the GluN1.1 CTD (blue) noting
joints for the C0, C1, and C2 splice cassettes; alignment of the membrane-proximal portions of GluN2A (green) and GluN2B (red)
noting location of conserved Tyr (Y) and Cys (C1, 2, 3) residues. B, Exposure to 15 M DHA (shaded bar) did not potentiate
whole-cell current evoked by 10M NMDA plus 10M glycine (open bars) in HEK cells cotransfected with wild-type GluN1.1 and
GluN2B truncated after S870 (top trace), but did potentiate for N2B truncation after E878 (middle trace) or V931 (bottom trace). C,
Plot of current (mean SEM) evoked immediately after exposure to DHA as a fraction of control current before DHA treatment for
wild-type and GluN2 truncated NMDA receptors. *, Significant difference fromwild-type ( p 0.0001, ANOVA on ranks with post
hoc Dunn’s test) and not significant difference from no effect (IDHA/Icontrol  1, t-statistic). # denotes that for the other N2
truncations IDHA/I control was significantly
1 but also significantly less than for wild-type receptors. D, Exposure to 15M DHA
(shaded bar) inhibited whole-cell current evoked by 10M kainate (open bars) in an HEK cell transfected with chimeric GluK2(R)
bearing a CTD fromGluN2B. Plot of current (mean SEM) evoked at the endof DHAexposure as a fraction of control current before
DHA treatment. *, DHA produced weak but significant ( p 0.030) inhibition of unedited (Q) chimeric GluK2 subunits and strong
inhibition of edited (R) chimeric receptors that was not different from wild-type GluK2(R) ( p  0.148). Inset, Proximal CTD
sequences of GluK2 and GluN2B indicating the position of the K2/2B joint.
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al., 1992; Nishikawa et al., 1994), but also in at least one experi-
ment on inside-out patches with exposure from the cytoplasmic
side (Casado and Ascher, 1998). We have not had success with
inside-out recordings from chimeric channels with NMDA re-
ceptor CTDs, possibly because of their relatively low expression
(Fig. 1C), nor have we attempted to elicit modulation in whole-
cell recordings by adding DHA to the internal solution, as lipo-
philic molecules often appear inactive
when delivered by intracellular dialysis
from the electrode (Jo and Bean, 2014).
Our results in the present study do con-
firm earlier evidence that anchorage to cy-
toplasmic scaffolding proteins by the
GluN2 distal C terminus is not essential
for modulation (Casado and Ascher,
1998), but they also reveal an absolute re-
quirement for the GluN2 proximal CTD
in potentiation by DHA. Further work
will be needed to determine the exact re-
lationship between mechanosensitivity
and allosteric regulation by fatty acids,
lysophospholipids, oxysterols, or other li-
pophilic modulators.
Previous work identified several post-
translational modifications within the
proximal CTD of GluN2A and GluN2B,
including tyrosine phosphorylation near
the cytoplasmic end of M4 (Vissel et al.,
2001) and palmitoylation of three con-
served cysteine residues within the first
30–40 CTD amino acids (Hayashi et al.,
2009). All of these modifications have
been implicated in the regulation of re-
ceptor trafficking: the tyrosine residue is
part of consensus binding motif for the
clathrin adaptor protein AP-2 present in
all four GluN2 subunits (Scott et al.,
2004). Phosphorylation of this Tyr stabi-
lizes receptors at the surface but is sup-
pressed by serine substitution at the three
proximal Cys residues of either GluN2A
or GluN2B. Thus, modification of proxi-
mal cysteines by palmitate thioesterifica-
tion has been suggested to reduce NMDA
receptor internalization by enhancing
phosphotyrosine levels (Hayashi et al.,
2009). Because robust potentiation by AA
(Casado and Ascher, 1998) or DHA (Ni-
shikawa et al., 1994) persists in outside-
out patches, it is likely to involve a direct
allosteric effect rather than a change in re-
ceptor trafficking to and from the surface
membrane (Linsenbardt et al., 2014). In-
deed, our results in the present study
indicate that allosteric potentiation by cis-
unsaturated fatty acids depends on the
three proximal cysteine residues but does
not require the conserved tyrosine that di-
rectly regulates internalization.
In summary, our study demonstrates
formation of functional heteromeric
NMDA receptor pores by chimeric sub-
units constructed by replacing intracel-
lular and extracellular portions of GluN1, GluN2A, and
GluN2B with homologous segments from kainate receptor
subunit GluK2. In addition, we demonstrate that distinct
NMDA receptor domains underlie positive allosteric modula-
tion by PS, 24(S)-hydroxycholesterol, and DHA. Although
further work will be needed to understand the detailed mech-
anisms that underlie channel regulation, one possible inter-
Figure 8. Proximal GluN2 CTD substitutions prevent DHA potentiation. A, Plot of current (mean SEM) evoked immediately
after exposure to DHA as a fraction of control current before DHA treatment for NMDA receptors with wild-type GluN1 and the
indicated substitutions to full-length GluN2. Residues highlighted in yellow arewild-type. *, Significant difference fromwild-type
( p 0.0001, ANOVAon rankswith post hocDunn’s test) andnot significant difference fromno effect (IDHA/Icontrol 1, t-statistic).
# denotes that for theN1wt/N2AY842F combination IDHA/Icontrol was significantly
1but also significantly less than forwild-type
receptors. B, Traces show the quadruple FAAAmutant lacked potentiation by DHA (top trace). Potentiation was preserved for the
Y842F substitution, in some cases reaching the level observed for wild-type receptors (bottom trace).
Figure 9. NMDA receptormodel with GluN2A proximal CTD. Homologymodel for GluN1/GluN2A generated byModeler (Eswar
et al., 2008) using PDB files 4PE5 (Karakas and Furukawa, 2014) and 4TLM (Lee et al., 2014) as templates and with twofold
symmetry constraint for the A/C and B/D subunits. Prediction for the proximal CTD generated by PEP-FOLD (The´venet et al., 2012)
with subsequent loop-refinement in Modeler. Palmitoylation at C1, 2, and 3 is expected to tether the proximal CTD to the
membrane.
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pretation is that our results implicate regions where each of
the modulators directly interacts with the receptor. Alter-
nately, these domains may be required for sensing specific
changes in membrane mechanical properties or contacting
other structural elements necessary for indirect modulation.
Our results with DHA identify an unexpected requirement for
three conserved cysteine residues in the proximal cytoplasmic
tail, suggesting that palmitoylation of these cysteines may be
important for fatty acid modulation. Establishing where and
how endogenous allosteric modulators act should facilitate
ongoing efforts (Collingridge et al., 2013; Zhu and Paoletti,
2015) to identify more potent and selective drugs capable of
upregulating or downregulating specific iGluR subpopula-
tions (Paoletti et al., 2013).
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